Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Deferred Stock Units | Award | $0 | +2.41 | +0.82% | $0.00 | 296 | Nov 10, 2022 | Common Stock | 2.41 | Direct | F1, F2, F3 | |
transaction | CLX | Deferred Stock Units | Award | $0 | +537 | +181.28% | $0.00 | 833 | Dec 30, 2022 | Common Stock | 537 | Direct | F1, F3, F4 | |
transaction | CLX | Deferred Stock Units | Award | $0 | +183 | +22.04% | $0.00 | 1.02K | Dec 30, 2022 | Common Stock | 183 | Direct | F1, F3, F5 |
Id | Content |
---|---|
F1 | 1-for-1 |
F2 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
F3 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
F4 | Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. |
F5 | Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. |